Daniels Eric Joseph 4
4 · KIORA PHARMACEUTICALS INC · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Daniels Eric Joseph
Chief Development Officer
Transactions
- Award
Common Stock
2023-03-03+15,600→ 25,838 total - Award
Stock Option (right to buy)
2023-03-03+10,400→ 10,400 totalExercise: $3.83Exp: 2033-03-03→ Common Stock (10,400 underlying)
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.